Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin

Riaz A. Memon(San Francisco VA Medical Center), Kenneth R. Feingold, Walter M. Holleran(San Francisco VA Medical Center), Judy K. Shigenaga(San Francisco VA Medical Center), Taisuke Seki(San Francisco VA Medical Center), Arthur H. Moser(San Francisco VA Medical Center), Yoshikazu Uchida(San Francisco VA Medical Center), John Fuller(University of Verona), Carl Grünfeld(San Francisco VA Medical Center)
Arteriosclerosis Thrombosis and Vascular Biology
August 1, 1998
10.1161/01.atv.18.8.1257
Cited by 164

Related Papers

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
|The Lancet|2008|450
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
|The Lancet|2008|432